Literature DB >> 25963590

Urinary tract infection: Ceftolozane-tazobactam gives a new ASPECT to the fight against antimicrobial resistance.

Jessica K Edwards.   

Abstract

Entities:  

Year:  2015        PMID： 25963590     DOI： 10.1038/nrneph.2015.77

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).

Authors:  Florian M Wagenlehner; Obiamiwe Umeh; Judith Steenbergen; Guojun Yuan; Rabih O Darouiche
Journal:  Lancet       Date:  2015-04-27       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.